Zhenhua Lin
About
In The Last Decade
Zhenhua Lin
86 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 1.7k
- Oncology 536
- Cancer Research 380
- Epidemiology 253
- Cell Biology 207
Countries citing papers authored by Zhenhua Lin
This map shows the geographic impact of Zhenhua Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenhua Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenhua Lin more than expected).
Fields of papers citing papers by Zhenhua Lin
This network shows the impact of papers produced by Zhenhua Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenhua Lin. The network helps show where Zhenhua Lin may publish in the future.
Co-authorship network of co-authors of Zhenhua Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Zhenhua Lin. A scholar is included among the top collaborators of Zhenhua Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenhua Lin. Zhenhua Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway | 1 |
| 5 | 16 | |
| 6 | 22 | |
| 7 | 11 | |
| 8 | 42 | |
| 9 | 15 | |
| 10 | 21 | |
| 11 | 23 | |
| 12 | 68 | |
| 13 | 147 | |
| 14 | 55 | |
| 15 | 107 | |
| 16 | 21 | |
| 17 | 33 | |
| 18 | 25 | |
| 19 | 22 | |
| 20 | LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer. | 17 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.